Table of Contents for the Digital Edition of Pharmaceutical Technology - March 2009 Pharmaceutical Technology - March 2009 Contents Critical Challenges Require Core Values API Outsourcing is Mixed Detective Work In the Field A Call for Transparency in Research and Marketing End-to-End Innovations Targeting Spending and Innovation Levels Is JIT Manufacturing the Right Prescription? Narrowing the Geographic Divide in API Sourcing Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films Ruggedness of Visible Residue Limits for Cleaning Validation UHPLC in the Contract Manufacturing Environment Extending Calibrations for Near Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data Heparin Monographs Further Revised The New Normal Pharma Capsules Industry Pipeline Product and Services Showcase/Marketplace Career Opportunities Ad Index In the Spotlight Changes to Vial Labels May Affect Patient Safety Pharmaceutical Technology - March 2009 Pharmaceutical Technology - March 2009 - (Page BB1) Pharmaceutical Technology - March 2009 - (Page BB2) Pharmaceutical Technology - March 2009 - Pharmaceutical Technology - March 2009 (Page Cover1) Pharmaceutical Technology - March 2009 - Pharmaceutical Technology - March 2009 (Page Cover2) Pharmaceutical Technology - March 2009 - Pharmaceutical Technology - March 2009 (Page 3) Pharmaceutical Technology - March 2009 - Pharmaceutical Technology - March 2009 (Page 4) Pharmaceutical Technology - March 2009 - Pharmaceutical Technology - March 2009 (Page 5) Pharmaceutical Technology - March 2009 - Pharmaceutical Technology - March 2009 (Page 6) Pharmaceutical Technology - March 2009 - Pharmaceutical Technology - March 2009 (Page 7) Pharmaceutical Technology - March 2009 - Contents (Page 8) Pharmaceutical Technology - March 2009 - Contents (Page 9) Pharmaceutical Technology - March 2009 - Contents (Page 10) Pharmaceutical Technology - March 2009 - Contents (Page 11) Pharmaceutical Technology - March 2009 - Critical Challenges Require Core Values (Page 12) Pharmaceutical Technology - March 2009 - Critical Challenges Require Core Values (Page 13) Pharmaceutical Technology - March 2009 - API Outsourcing is Mixed (Page 14) Pharmaceutical Technology - March 2009 - API Outsourcing is Mixed (Page 15) Pharmaceutical Technology - March 2009 - Detective Work (Page 16) Pharmaceutical Technology - March 2009 - Detective Work (Page 17) Pharmaceutical Technology - March 2009 - In the Field (Page 18) Pharmaceutical Technology - March 2009 - In the Field (Page 19) Pharmaceutical Technology - March 2009 - In the Field (Page 20) Pharmaceutical Technology - March 2009 - In the Field (Page 21) Pharmaceutical Technology - March 2009 - In the Field (Page 22) Pharmaceutical Technology - March 2009 - In the Field (Page 23) Pharmaceutical Technology - March 2009 - In the Field (Page 24) Pharmaceutical Technology - March 2009 - In the Field (Page 25) Pharmaceutical Technology - March 2009 - In the Field (Page 26) Pharmaceutical Technology - March 2009 - In the Field (Page 27) Pharmaceutical Technology - March 2009 - In the Field (Page 28) Pharmaceutical Technology - March 2009 - In the Field (Page 29) Pharmaceutical Technology - March 2009 - In the Field (Page 30) Pharmaceutical Technology - March 2009 - In the Field (Page 31) Pharmaceutical Technology - March 2009 - In the Field (Page 32) Pharmaceutical Technology - March 2009 - In the Field (Page 33) Pharmaceutical Technology - March 2009 - In the Field (Page 34) Pharmaceutical Technology - March 2009 - In the Field (Page 35) Pharmaceutical Technology - March 2009 - In the Field (Page 36) Pharmaceutical Technology - March 2009 - In the Field (Page 37) Pharmaceutical Technology - March 2009 - In the Field (Page 38) Pharmaceutical Technology - March 2009 - In the Field (Page 39) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 40) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 41) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 42) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 43) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 44) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 45) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 46) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 47) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 48) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 49) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 50) Pharmaceutical Technology - March 2009 - A Call for Transparency in Research and Marketing (Page 51) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 52) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 53) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 54) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 55) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 56) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 57) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 58) Pharmaceutical Technology - March 2009 - End-to-End Innovations (Page 59) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 60) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 61) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 62) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 63) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 64) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 65) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 66) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 67) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 68) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 69) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 70) Pharmaceutical Technology - March 2009 - Targeting Spending and Innovation Levels (Page 71) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 72) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 73) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 74) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 75) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 76) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 77) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 78) Pharmaceutical Technology - March 2009 - Is JIT Manufacturing the Right Prescription? (Page 79) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 80) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 81) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 82) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 83) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 84) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 85) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 86) Pharmaceutical Technology - March 2009 - Narrowing the Geographic Divide in API Sourcing (Page 87) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 88) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 89) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 90) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 91) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 92) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 93) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 94) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 95) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 96) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 97) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 98) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 99) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 100) Pharmaceutical Technology - March 2009 - Formulation Effects on the Thermomechanical Propertiesand Permeability of Free Films and Coating Films (Page 101) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 102) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 103) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 104) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 105) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 106) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 107) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 108) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 109) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 110) Pharmaceutical Technology - March 2009 - Ruggedness of Visible Residue Limits for Cleaning Validation (Page 111) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 112) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 113) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 114) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 115) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 116) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 117) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 118) Pharmaceutical Technology - March 2009 - UHPLC in the Contract Manufacturing Environment (Page 119) Pharmaceutical Technology - March 2009 - Extending Calibrations for Near Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos (Page 120) Pharmaceutical Technology - March 2009 - Extending Calibrations for Near Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos (Page 121) Pharmaceutical Technology - March 2009 - Extending Calibrations for Near Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos (Page 122) Pharmaceutical Technology - March 2009 - Extending Calibrations for Near Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos (Page 123) Pharmaceutical Technology - March 2009 - Extending Calibrations for Near Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos (Page 124) Pharmaceutical Technology - March 2009 - Extending Calibrations for Near Infrared Assay of Tablets Using Synthetic Modeling and Variance from Placebos (Page 125) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 126) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 127) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 128) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 129) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 130) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 131) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 132) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 133) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 134) Pharmaceutical Technology - March 2009 - Modeling Pharmaceutical Powder-Flow Performance Using Particle-Size Distribution Data (Page 135) Pharmaceutical Technology - March 2009 - Heparin Monographs Further Revised (Page 136) Pharmaceutical Technology - March 2009 - Heparin Monographs Further Revised (Page 137) Pharmaceutical Technology - March 2009 - The New Normal (Page 138) Pharmaceutical Technology - March 2009 - The New Normal (Page 139) Pharmaceutical Technology - March 2009 - The New Normal (Page 140) Pharmaceutical Technology - March 2009 - The New Normal (Page 141) Pharmaceutical Technology - March 2009 - Pharma Capsules (Page 142) Pharmaceutical Technology - March 2009 - Pharma Capsules (Page 143) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 144) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 145) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 146) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 147) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 148) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 149) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 150) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 151) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 152) Pharmaceutical Technology - March 2009 - Industry Pipeline (Page 153) Pharmaceutical Technology - March 2009 - Product and Services Showcase/Marketplace (Page 154) Pharmaceutical Technology - March 2009 - Product and Services Showcase/Marketplace (Page 155) Pharmaceutical Technology - March 2009 - Product and Services Showcase/Marketplace (Page 156) Pharmaceutical Technology - March 2009 - Product and Services Showcase/Marketplace (Page 157) Pharmaceutical Technology - March 2009 - Product and Services Showcase/Marketplace (Page 158) Pharmaceutical Technology - March 2009 - Career Opportunities (Page 159) Pharmaceutical Technology - March 2009 - Career Opportunities (Page 160) Pharmaceutical Technology - March 2009 - In the Spotlight (Page 161) Pharmaceutical Technology - March 2009 - Changes to Vial Labels May Affect Patient Safety (Page 162) Pharmaceutical Technology - March 2009 - Changes to Vial Labels May Affect Patient Safety (Page Cover3) Pharmaceutical Technology - March 2009 - Changes to Vial Labels May Affect Patient Safety (Page Cover4) http://digital.findpharma.com/nxtbooks/advanstar/pt_201202_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201202 http://digital.findpharma.com/nxtbooks/advanstar/pt_201201 http://digital.findpharma.com/nxtbooks/advanstar/pt_201112 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201110 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201108 http://digital.findpharma.com/nxtbooks/advanstar/pt_201108_supplmnt http://digital.findpharma.com/nxtbooks/advanstar/pt_201107 http://digital.findpharma.com/nxtbooks/advanstar/pt_201106 http://digital.findpharma.com/nxtbooks/advanstar/pt_201105_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201105 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201103 http://digital.findpharma.com/nxtbooks/advanstar/pt_201102 http://digital.findpharma.com/nxtbooks/advanstar/pt_201101 http://digital.findpharma.com/nxtbooks/advanstar/pt_201012 http://digital.findpharma.com/nxtbooks/advanstar/pt_201011 http://digital.findpharma.com/nxtbooks/advanstar/pt_201010 http://digital.findpharma.com/nxtbooks/advanstar/pt_201009 http://digital.findpharma.com/nxtbooks/advanstar/pt_201008 http://digital.findpharma.com/nxtbooks/advanstar/pt_201007 http://digital.findpharma.com/nxtbooks/advanstar/pt_201006 http://digital.findpharma.com/nxtbooks/advanstar/pt_201005 http://digital.findpharma.com/nxtbooks/advanstar/pt_201004 http://digital.findpharma.com/nxtbooks/advanstar/pt_201003 http://digital.findpharma.com/nxtbooks/advanstar/pt201002 http://digital.findpharma.com/nxtbooks/advanstar/pt_201001 http://digital.findpharma.com/nxtbooks/advanstar/pt_200912 http://digital.findpharma.com/nxtbooks/advanstar/pt_200911 http://digital.findpharma.com/nxtbooks/advanstar/pt10_2009 http://digital.findpharma.com/nxtbooks/advanstar/pt_200909 http://digital.findpharma.com/nxtbooks/advanstar/pt_200908 http://digital.findpharma.com/nxtbooks/advanstar/pt_200907 http://digital.findpharma.com/nxtbooks/advanstar/pt_200906 http://digital.findpharma.com/nxtbooks/advanstar/pt_200905 http://www.nxtbook.com/nxtbooks/advanstar/pt_200904 http://www.nxtbook.com/nxtbooks/advanstar/pt_200903 http://www.nxtbook.com/nxtbooks/advanstar/pt_200902 http://www.nxtbook.com/nxtbooks/advanstar/pt_200901 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.